Latest Asx Trading News

LTR Pharma has confirmed it disclosed a binding US commercialisation agreement for ROXUS promptly after signing, responding to ASX scrutiny over pre-announcement trading activity.

Nova Minerals' US holding company shares and warrants are slated to begin trading on NYSE American on 17 June 2026, with ASX trading of CHESS Depositary Interests following on 18 June, marking a key step in the company’s US redomiciliation.

Amaero Ltd’s Federal Court-approved re-domiciliation schemes take effect on 11 June 2026, halting ASX trading of existing shares and paving the way for new US HoldCo CDIs to list.

The Supreme Court of Western Australia has approved ACAM GP Limited’s full acquisition of Hartshead Resources via a scheme of arrangement, setting the stage for the company’s ASX suspension and shareholder payouts next month.

Amaero Ltd has obtained Federal Court approval to re-domicile to Delaware via schemes exchanging Australian shares and options for US HoldCo equivalents, marking a major structural shift.

Antilles Gold’s Cuban joint venture Minera La Victoria has been hit with US sanctions, prompting a suspension of the company’s direct involvement and halting trading of its shares and options.

The Supreme Court of Western Australia has approved Genesis Minerals’ acquisition of Magnetic Resources, setting a clear timetable for scheme implementation and ASX trading suspension.

Hartshead Resources held a pivotal scheme meeting on 8 June 2026 to approve ACAM GP Limited’s acquisition offer, featuring a 133% premium and unanimous board support. The outcome now hinges on final court approval.

The Supreme Court of New South Wales has approved schemes of arrangement that transfer Nova Minerals' ownership to a new US holding company, with ASX trading set to suspend immediately.

Opthea Limited resumes ASX trading as it pivots to develop OPT-302 for lymphangioleiomyomatosis, outlining a disciplined 18-month staged clinical program backed by A$31.2 million in cash.

Corporate Travel Management reports progress on UK customer remediation with funding plans underway and final agreements near completion. The company maintains strong client retention above 97% and aims to release audited FY25 and reviewed 1H26 financials by end of June, eyeing a swift return to ASX trading.

Nova Minerals shareholders and Nasdaq warrantholders overwhelmingly approved schemes to restructure the company under a new US holding entity, pending final court approval.